1. Home

We invite you to submit scientific poster abstracts for the 21st Annual meeting in Boston on October 15-17, 2026.  

Multidisciplinary clinicians from across the country will gather to discuss the most up-to-date developments in cardiometabolic health, including dyslipidemia, heart failure, hypertension, type 2 diabetes, weight management, and chronic kidney disease.  To enrich the attendee experience, we will offer scientific poster sessions to share the latest information from current research and clinical findings. Abstracts should address evidence-based practices and state of art clinical research that are relevant to frontline practitioners who treat patients with cardiometabolic disease.  Submit your abstract now and stay tuned for more information about selection for publication in early 2027.

Deadlines

The abstract submission due date is: September 1, 2026
Notification of abstract status on or before: September 15, 2026

Application Form (Required for Industry only)

All posters from industry are required to complete an application form first which can be submitted here.

Applications will be reviewed, and approval notifications will be sent. Please do NOT submit your industry abstract until your application has been processed and you have been notified to move forward. For any questions regarding the application process, please contact exhibits@cardiometabolichealth.org.

Submission Details

1. Completion of all submission form questions and abstract components is required.
2. Abstracts may be of original research or encore (repeat) presentations of abstracts, i.e., CMHC will accept abstracts that have already been presented at other medical conferences. 
3. Author requirements: 
   • Author lists and affiliations 
   • List names of all authors, in order in which you wish them to appear in printed text. 
   • No more than 10 authors should be listed. 
   • List corresponding author and email address.
4. A fully structured abstract should be 1,100 words or less. Author lists, correspondence information, disclosures, and acknowledgements are not part of this word limit: 
   • Background: 200 words 
   • Purpose: 150 words 
   • Methods: 200 words 
   • Results: 350 words 
   • Conclusions/Implications for future research and/or clinical care: 200 words 
5. Do not use tables, charts, or graphs in your abstract submission (they can be included in the printed poster).
6. There is no limit to the number of abstracts one author may submit for consideration.
7. The first author is responsible for communicating all of these policies to all involved parties. 
8. Completion of required copyright agreement.
9. List disclosures (financial and/or in-kind support). If none, state “Nothing to disclose by any author(s).”
10. List acknowledgements.
    1. Encore presentations: If you have previously presented your work/data as an abstract at another conference, then please list this under your Acknowledgements section.
    2. AI use: If an AI tool is used during the drafting process of the abstract, the author should disclose their use of generative AI by including it in the Acknowledgements section with the following: 
       • The statement: This abstract was initially drafted using an AI tool. The authors have reviewed, revised, and finalized the content to ensure accuracy, originality, and alignment with the intended research objectives.
       • The full name of the tool used (with the version number), how it was used, and the reason for its use.

 

For Accepted Abstracts 

Meeting Registration Requirements 

All accepted abstracts (both industry and non-industry) must have a registered presenter at the 2026 meeting. Submission of an abstract does not automatically register you for the conference.

Onsite Poster Presentation Requirements

Presenters must remain at their assigned poster station during designated presentation times to engage with attendees and respond to questions. No formal oral presentation is required.  Posters will be displayed on Thursday, October 15 and Friday, October 16. Presenters will be sent their assigned date, time slots, poster number, and onsite instructions closer to the meeting date.

 

Non-Industry Discounts

• Non-Students/Non-Industry: a $200 off discount code will be provided to those with accepted abstracts.  
• Students only: students with an accepted abstract will be sent a complimentary registration code (ID required) 

Disclosures

CMHC requires faculty and poster authors/presenters who have an interest in selling a technology, program, product, and/or service to healthcare professionals to disclose this information in the submission proceess in order to be considered for and/or present at any CMHC educational session. 

Publication

If your abstract is accepted, you will be notified on or by September 15, 2026, and the abstract will be posted online before the meeting. Only accepted abstracts will be posted online. Abstracts will be published in an open access supplement to the peer-reviewed journal Postgraduate Medicine in January 2027*. Abstracts will only be published with the journal if there is a registered presenter at the live meeting.  *estimated timeframe only and subject to change

To view the 2025 abstracts, click here. 

 

Print and Presentation Guidelines 

Please bring a physical copy of your poster to the live meeting for presentation. Below are the poster specifications and guidelines. 

Print Specifications 

• Printing: Posters should be printed on matte paper in a horizontal orientation.
• Size: 24″ high x 36″ wide.
• Onsite Requirement: Posters must be mounted on foam board to be displayed in the poster hall. CMHC will provide a table, pins, and a table easel to hold your foam board-mounted poster.
• Important: While your poster can be printed and rolled up for easy transport, mounting on foam board is required for display. Please note that we do not supply foam boards. You have two options: (1) print your poster on paper and mount it to a foam board using pins we provide, or (2) print your poster directly onto a mounted foam board.

Printing and Foam Board Purchase at the Meeting: The Boston Park Plaza has a FedEx office onsite where you can order and pick up your poster. You may choose to print your poster directly on their foam board or purchase a plain foam board to mount your pre-printed poster. If you plan to print your poster onsite, we recommend placing your order at least one week before the meeting to ensure timely preparation. For pricing inquiries, please contact the onsite FedEx office using the information below:

• FedEx Information:
  • https://www.office.fedex.com/default/mounted-poster.html 
  • Address: Boston Park Plaza | 50 Park Plaza, Boston, MA , 02116
  • Phone: 617-423-0204
  • Email: usa5690@fedex.com
  • Hours Of Operation
    • Mon-Fri 7:30 A.M. – 6:00 P.M. ET
    • Sat 8:00 A.M. – 12:00 P.M. ET
    • Sun Closed 

FedEx print dates and times above may change, please be sure to check the direct FedEx store website for the latest information by clicking here.

Guidelines 

1. While first authors typically attend the conference in person, CMHC allows other listed authors to attend in his/her place. Additional authors who are attending the conference will also need to be a registered attendee. 
2. Authors/presenters should bring their posters with them to the conference. Please do not send posters to the CMHC offices or in care of CMHC. 
3. Your poster may include figures, graphs, tables, and charts. 
4. No trade names should be used for drugs, devices, or instrumentation. Any medications or substances referred to in the materials must be identified by their scientific names only. 
5. Recording by any means (photographing, audiotaping, videotaping) of any presentation/session is prohibited, except by a CMHC authorized agent or by first author(s) who wish to photograph their own poster presentation. Violators risk confiscation of their equipment and/or dismissal from CMHC. 
6. QR codes with a maximum size of 1”x1” are permitted in the lower corner of posters. Scanning of a QR code only by participants using smart phones or other mobile devices is permissible. 
7. Interactive content/features on printed posters that can be viewed using smartphones or iPADs is allowed (for example, additional graphs, animations, videos related to the printed poster content). 
8. Presenters may use an iPad or tablet to facilitate their presentation, but it cannot be used in lieu of a printed poster. Tablets may also be available for viewers to see the interactive content during the poster presentation time. 
9. Supplementary information on how to download relevant QR codes and access interactive content may be included on the poster, i.e., within the text of the poster or printed on the bottom. 
10. List acknowledgements.
    1. Encore presentations: If you have previously presented your work/data as an abstract at another conference, then please list this under your Acknowledgements section.
    2. AI use: If an AI tool is used during the drafting process of the abstract, the author should disclose their use of generative AI by including it in the Acknowledgements section with the following: 
       • The statement: This abstract was initially drafted using an AI tool. The authors have reviewed, revised, and finalized the content to ensure accuracy, originality, and alignment with the intended research objectives.
       • The full name of the tool used (with the version number), how it was used, and the reason for its use.
11. For all abstracts involving human or animal studies, please ensure to state the approval by the relevant ethics committees.
12. All accepted abstracts will be contacted closer to the meeting date with an assigned date and poster number, as well as onsite instructions. 
13. All accepted abstracts will also have the option to submit a short audio file plus a PDF version of the accepted poster to be added to the CMHC website.
14. If an author wants to change or withdraw their abstract, they must contact our staff by October 2, 2026. No update requests are permitted after this date. Send requests via email to karin.mcadams@informa.com. 

Late-Breaking Abstracts 

The CMHC late-breaking abstracts policy allows for the submission of late-breaking abstracts only for randomized phase II and phase III trials for which no preliminary data are available at the time of the abstract submission deadline (September 1, 2026), but for which a preplanned analysis of the primary endpoint is scheduled after that date but before October 1, 2026 (deadline for the final, updated late-breaking abstract). During abstract submission, you will be required to provide the date of planned analysis. The policy is not a mechanism to allow for updated data to be submitted later when preliminary data are available by the abstract submission deadline. Late-breaking abstracts must follow the same abstract guidelines listed on this page. To submit a late-breaking abstract, please email your request to karin.mcadams@informa.com. 

 

Submission Portal

Abstracts submissions can be made below.

Enter Portal

The abstract submission due date is: September 1, 2026

Notification of abstract status on or before: September 15, 2026

 

Reminder for ALL industry posters: All posters from industry are required to complete an application form first which can be submitted here. Applications will be reviewed, and approval notifications will be sent. Please do NOT submit your industry abstract until your application has been processed and you have been notified to move forward. For any questions regarding the application process, please contact exhibits@cardiometabolichealth.org.